RxDoctor Payments Data

Yelena Selektor, MD

Advanced Heart Failure and Transplant Cardiology · Detroit, MINPI 1265561518

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Abbott accounts for 76.3% of it on its own, with 5 other manufacturers making up the rest. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in MI, where the typical reported total is $2,630.

$2,131in general payments, 2019–2025

Across 21 payments — averaging $101.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Novo Nordisk$179
  • Abiomed$146
  • Bridgebio Pharma, Inc.$131
  • Procyrion, Inc.$37
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$14
$175,626in research payments, 2019–2025

Across 34 payments — averaging $5165.47 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$114K
  • Bayer$60K
  • Actelion Pharmaceuticals, Ltd$2K

What the payments were for

  • Food & beverage$2,06797%
  • Education$653%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,131 in reported general payments places this provider in the 45th percentile of 27 advanced heart failure and transplant cardiology providers in Michigan.

See all advanced heart failure and transplant cardiology providers in Michigan

Medicare billing

Part B allowed, 2024
$22,635
Medicare patients
79
Services billed
246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan137$141,324
JardianceEmpagliflozin50$52,123
FarxigaDapagliflozin Propanediol36$52,013
EliquisApixaban42$48,367
Envarsus XrTacrolimus19$10,628
Sirolimus29$6,574
Tacrolimus95$6,070
Enoxaparin Sodium33$5,126
Potassium Chloride44$4,565
Bumetanide70$3,074
Mycophenolate Mofetil44$3,022
Isosorbide Dinitrate27$1,956
Hydralazine Hcl56$1,841
Warfarin Sodium94$1,574
Atorvastatin Calcium103$1,313

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →